Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Puma Biotechnology (PBYI) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2012. Compare with PBYI stock chart to see long term trends.

PBYI stock compared to

PBYI Income Statement

Revenue, Net:52557000
Revenue Per Share:1.33
Selling, General & Admin Expense:28606000
Research & Development Expense:24160000
Total Operating Expenses:63706000
Operating Income:-40535000
Net Income:-14994000
Earnings Per Share, Basic:-0.39
Shares Outstanding, Basic Avg:39576107

PBYI Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:2948000
Change in Accounts Receiveable:-594000
Net Cash from Operations:-5635000
Net Cash from Investing Activities:823000
Net Change in Cash & Equivalents:-4789000

PBYI Balance Sheet

Cash and Cash Equivalents:97454000
Short-Term Investments:8096000
Accounts Receivable, Net:25543000
Inventories:3454000
Total Current Assets:146139000
Property, Plant & Equipment, Net:2481000
Total Assets:244220000
Accounts Payable:12076000
Current Portion of Long-Term Debt:14286000
Total Short-Term Liabilities:114255000
Long Term Debt, Non-Current Portion:84025000
Total Liabilities:250171000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group Inc
3,473,796 sh
-852,192 sh
-20%
$35,050
-$10,069
Fred Alger Management, LLC
3,332,523 sh
858,494 sh
35%
$33,625
$7,821
Blackrock Inc.
2,957,405 sh
1,109 sh
0%
$29,839
-$995
Deerfield Management Company, L.P. (Series C)
2,826,327 sh
2,826,327 sh
NEW
$28,518
$28,518
Deerfield Management Company, L.P. (Series C)
2,826,327 sh
2,826,327 sh
NEW
$28,518
$28,518
Renaissance Technologies LLC
1,551,697 sh
86,000 sh
6%
$15,657
$370
Great Point Partners LLC
1,102,073 sh
1,009,571 sh
1091%
$11,120
$10,155
Goldman Sachs Group Inc
907,080 sh
-77,600 sh
-8%
$9,153
-$1,118
Northern Trust Corp
372,472 sh
-21,534 sh
-5%
$3,758
-$352
Prudential Financial Inc
346,521 sh
244,240 sh
239%
$3,497
$2,430
Charles Schwab Investment Management Inc
322,245 sh
-252 sh
0%
$3,252
-$112
Panagora Asset Management Inc
293,760 sh
-2,303 sh
-1%
$2,964
-$124
Ameriprise Financial Inc
259,750 sh
48,055 sh
23%
$2,620
$414
AXA
180,700 sh
 
$1,823
AXA
180,700 sh
 
$1,823
Sei Investments Co
178,408 sh
28,232 sh
19%
$1,799
$233
Bank Of America Corp /De/
164,288 sh
-109,016 sh
-40%
$1,658
-$1,193
Morgan Stanley
139,397 sh
93,198 sh
202%
$1,406
$924
Credit Suisse Ag/
122,176 sh
-44,311 sh
-27%
$1,232
-$504
Jacobs Levy Equity Management, Inc
104,543 sh
-4,146 sh
-4%
$1,055
-$79

Data imported from Puma Biotechnology Inc SEC filings. Check original filings before making any investment decision.